observ
fowl
erythrocyt
agglutin
influenza
virus
repres
mileston
develop
virolog
hirst
mcclelland
hare
extens
research
stimul
discoveri
subject
earlier
review
seri
buazel
hanig
phenomenon
hemadsorpt
also
first
describ
conncction
influenza
virus
shelokov
e
al
reflect
interact
erythrocyt
viral
envelop
compon
number
virus
unrel
myxovirus
sinc
shown
agglutin
erythrocyt
variou
speci
mechan
case
appear
differ
basic
myxovirus
instanc
precis
knowledg
group
involv
either
erythrocyt
surfac
virion
regardless
underli
mechan
proof
hemagglutin
due
viral
agent
hand
depend
wlh
visibl
reaction
inhibit
antibodi
direct
whole
viral
particl
activ
surfac
structur
specif
inhibit
hemagglutin
antibodi
thu
support
grant
nation
instihtc
health
present
address
louisiana
state
univers
medic
center
new
orlean
louisiana
major
asset
recognit
import
immunolog
relationship
within
among
differ
group
aninl
virus
n
review
attemptcd
summar
experiment
evid
bear
thc
natur
viruserythrocyt
reaction
cliaracterist
scveral
taxonom
group
evid
cull
studi
condit
necessari
hemagglutin
examiriatiol
specif
factor
affect
either
cell
virion
enhanc
alter
abolish
reaction
direct
physicoclern
analysi
cell
virus
receptor
analog
consid
discuss
passiv
hemagglutin
reaction
use
measur
antibodi
viral
antigen
adsorb
tan
erythrocyt
eg
haa
hcmagglutinin
form
viral
infect
indcpcndcntli
matur
virion
cg
vaccinia
ultrastructurc
composit
erythrocytc
membran
constitut
field
studi
cxpand
rapidli
attempt
made
encompass
extens
literatur
subject
except
particular
aspect
concern
review
histor
interest
influcnea
viruserythrocyteglyccprotein
inhibitor
model
serv
import
link
relat
biolog
function
red
cell
membran
structurc
influenza
viru
receptor
intim
associ
receptor
isoantibodi
name
blood
group
antigen
b
h
mi
n
scrvc
addit
marker
recogn
biolog
activ
purifi
rnembrrmc
fraction
n
broad
analog
viru
receptor
analog
structur
antigen
determin
blood
group
spccific
elucid
primari
analysi
erythrocyt
extcnsiv
studi
solubl
blood
group
substanc
deriv
froin
sourcc
red
cell
mn
antigen
constitut
cxception
statcmcnt
sinc
found
erythrocyt
fact
form
part
glycoprotein
complex
contain
viru
receptor
activ
direct
approach
chcinic
characterizatiori
variou
receptor
activ
lie
attempt
render
erythrocyt
membran
solublc
separ
compon
standard
method
protein
carbohydr
chemistri
much
depend
initi
natur
thc
start
materi
render
solubl
onc
mean
anoth
plasma
protein
leukocyt
platelet
possibl
sourc
contamin
separ
crythrocyt
lysi
method
lysi
use
obtain
stroma
posthemolyt
residu
also
ixriport
bear
puriti
end
product
sinc
hemoglobin
cytoplasm
constitu
readili
occlud
cling
tenaci
membran
red
cell
lyse
distil
water
hypoton
lysi
care
controllcd
condit
ph
ionic
strength
pure
erythrocyt
ghost
obtain
dodg
et
al
membran
retain
virtual
lipid
intact
cell
fact
along
antigen
distinct
cytoplasm
constitu
make
prepar
accept
intact
cell
membran
appear
biconcav
disk
view
phasecontrast
microscopi
virtual
free
hemoglobin
determin
colorimetr
immunolog
analysi
electron
microscopi
howe
et
al
tabl
present
simplifi
summari
sever
method
use
partit
membran
posthemolyt
residu
biolog
activ
subfract
term
posthemolyt
residu
tcrirlcd
signifi
rel
crude
prepar
stroma
contrast
membran
retain
morpholog
chemic
ident
tire
uncontamin
hemoglobin
plasma
protcin
form
element
hot
phenol
extract
membran
separ
aqueou
phase
glycoprotcin
kathan
et
al
fuither
purifi
fraction
etlislnol
precipit
variou
comhinalion
gel
filtrat
chromatographi
springer
et
al
find
product
free
lipid
contain
virtual
sialic
acid
npproxirnntcli
linlf
hexosc
amino
sugar
membran
ttnd
complet
solubl
water
sevcrnl
diffcrcnt
criteria
includ
polyacrylumidc
gel
clectrophoresi
page
ultracentrifug
analysi
tiid
immunoelectrophoresi
repres
singl
compon
electron
microscop
examin
prepar
erythrocyt
glycoprotein
consid
pure
criteria
neg
stain
witjh
phosphoturigst
acid
examin
electron
microscopi
fig
l
seen
prepar
compris
homogen
array
particl
although
conclus
size
configur
drawn
due
hypcrton
stain
solut
exactli
compartiblc
prepar
murir
erythrocyt
shown
particl
seen
close
similar
human
siibstanc
size
uniform
fig
tiic
yield
glycoprotein
hurnsn
crythrooyt
rcportetl
enli
mccd
membran
wcrc
extract
first
lilliiiirn
diiodosrilicyl
id
aqueou
phenol
marchesi
andrew
glycoprotein
purifi
manner
show
mtigcnic
ident
vr
mn
substanc
prcviousli
describ
recent
electrophoret
studi
variou
glycoprotcin
includ
lisphenolderiv
erythrocyt
materi
shown
appar
molecular
weight
vari
degre
acrylamid
cross
link
segrest
et
al
light
find
molecular
weight
previous
determin
phenolderiv
glycoprotein
vr
mn
substanc
page
reevalu
cf
tabl
stromal
glycoprotein
inhibitor
influenza
viru
hemagglutin
contain
polysaccharid
moieti
determin
n
blood
group
antigen
kathan
et
al
howe
et
al
springer
et
al
thu
may
consid
encompass
site
erythrocyt
surfac
myxovir
hemagglutinin
attach
ie
viru
receptor
substanc
vr
surfac
glycoprotein
site
associ
appear
extens
intramembran
particl
reveal
freezeetch
techniqu
electron
microscopi
antibodi
evok
rabbit
inject
vr
complet
freund
adjuv
may
direct
particular
blood
group
antigen
contain
polysaccharid
moieti
springer
et
al
also
protein
portion
vr
molecul
latter
antibodi
broadli
crossreact
one
individu
vr
prepar
anoth
independ
blood
group
antigen
antibodi
vr
label
ferritin
react
specif
intact
erythrocyt
well
extern
surfac
hemoglobinfre
membran
figur
show
electron
micrograph
reaction
block
prior
absorpt
label
antiserum
pure
vr
howe
et
al
trypsin
treatment
inactiv
receptor
myxovirus
erythrocyt
purifi
vr
result
electrophoret
motil
erythrocyt
aqd
glycoprotein
reduc
effect
account
cleavag
sialopeptid
erythrocyt
glycoprotein
cook
et
al
structur
model
propos
compon
insert
erythrocyt
winzler
trypsinsensit
fragment
consid
amino
end
linear
polypeptid
anchor
among
cell
lipid
carboxyl
end
along
polypeptid
chain
seri
oligosaccharid
residu
nacetylneuramin
acid
nana
termin
bound
termin
bound
nana
account
predominantli
anion
natur
cell
surfac
rapid
electrophoret
mobil
intact
pure
glycoprotein
cook
et
al
howe
lee
danon
e
al
oligosaccharid
side
chain
attach
peptid
oglycosid
linkag
acetylgalactosamin
serin
threonin
nglycosid
linkag
nacetylglucosamin
aspart
acid
residu
pure
glycoprotein
characterist
high
content
three
amino
acid
winzler
kathan
dctnil
x
specif
reaction
human
erythrocyt
membran
ferritindabel
antibodi
vr
erythrocyt
react
antibodi
wash
free
nonspecif
protein
ferritin
lyse
addit
complement
cell
membran
wash
free
hemoglobin
fix
glutaraldehyd
osmium
tetroxid
x
b
portion
hemoglobinfre
membran
prepar
hypoton
lysi
dodg
et
al
allow
react
antibodi
wash
phosphatebuff
salin
fix
gluiaraldetiydc
neg
stain
pta
x
courtesi
dr
thoma
bachi
et
springer
et
al
howe
et
al
thc
trypsinrcleas
sialopcptid
carri
prosthet
group
necessari
viru
attach
cell
inhibit
influenza
viral
hemagglutinin
purifi
glycoprotein
sialopcptid
also
carri
determin
n
blood
group
antigen
recogn
intact
glyco
show
determin
react
antii
arc
containcd
alkalist
trisaccharid
obtain
borohydrid
degrad
vr
nana
previous
bcen
rcmovcd
mild
acid
hydrolysi
phcnolderiv
glycoprotein
sever
speci
differ
one
anoth
significantli
respect
monosaccharid
composit
content
correspond
amino
acid
residu
involv
carbohydratcprotein
linkag
howe
et
al
treatment
hemoglobinfre
memhran
aqueou
pyridin
result
partit
protein
solubl
fraction
contain
membran
sialic
acid
irisolublc
fraction
contain
membran
lipid
blumenfeld
et
al
sephadox
presenc
pyridin
sialoprotein
separatcd
compon
lack
sugar
residu
thc
sialoprotein
fraction
least
one
compon
share
antigen
ident
vr
undoubtedli
account
viru
inhibitori
action
thc
sinloprotein
fraction
tabl
viru
rcccptor
activ
pyridinedcriv
sialoprotein
nppreciabl
lower
pure
vr
may
bccri
due
presenc
nonreact
compon
nrrangcment
complementari
prosthet
group
icss
cfficicnt
vr
bind
viral
surfac
n
amino
acid
analysi
pyridinederiv
sialoprotein
gave
high
serin
tlircoriiri
valu
compar
purifi
vr
strongli
support
tile
conclus
larg
molecular
weight
glycoprotein
entiti
distinct
thc
siiialler
protein
thc
solubl
fraction
coritaincd
littl
sialic
acid
howe
et
al
nbutanol
use
number
investig
howe
et
al
maddi
membran
compon
portion
tlic
rncrrlbrane
protein
thu
render
water
solubl
presum
separ
lipid
lipoprotein
enter
butanol
phase
sever
cxtraction
requir
reinov
lipid
watersolublc
fraction
compriscd
scvcral
compoiient
coritaincd
sialic
acid
viru
receptor
blood
group
activ
whittcmorc
et
al
one
compon
crossreact
antigen
pure
vr
howe
ee
bc
note
subsequ
erythrocyt
rcceptor
scvcrnl
group
rnyxovirusc
hnvc
bccn
describ
basi
inliibitori
activ
demonstr
mixtur
membran
compon
watersolubl
fraotion
refer
receptor
howev
rccogniz
statc
puriti
compar
vr
combin
variou
method
use
determin
total
number
individu
protein
present
crythrocyt
membran
prepar
hypoton
lysi
free
hemoglobin
cytoplasm
constitu
rosenberg
guidotti
subject
ghost
sequenti
extract
edta
nacl
ethanoleth
result
lipidfre
residu
contain
sialic
acid
membran
resolv
gel
electrophoresi
five
addit
fraction
two
account
sialic
acid
start
materi
two
sialoprotein
fraction
molecular
weight
rang
monomer
form
vr
obtain
phenol
extract
membran
compon
separ
gel
electrophoresi
size
rang
nh
termin
end
group
analys
indicatcd
consist
differ
among
protein
variou
fraction
minimum
twelv
differ
polypeptid
chain
judg
present
membran
result
compar
thosc
anoth
studi
hemoglobinfre
membran
dissolv
sd
heat
minut
order
disaggreg
protein
complet
sephadex
chromatographi
reveal
presenc
least
compon
molecular
weight
rang
two
contain
carbohydrateon
molecular
weight
second
smaller
rapid
compon
thought
glycolipid
lenard
n
latter
studi
multipl
compon
sd
gel
critic
exclud
due
random
aggreg
visibl
result
viral
hemagglutin
pattern
form
bottom
test
tube
well
plate
lattic
red
cell
lightli
conjoin
viral
hemagglutinin
salk
stabil
pattern
vari
invers
abil
viru
elut
hemagglutin
serv
use
direct
mean
titer
intact
viral
particl
hemagglutin
subunit
sinc
hemagglutin
simpl
twocompon
system
titer
given
prepar
depend
concentr
viral
particl
state
aggreg
concentr
erythrocyt
ph
temperatur
instanc
presenc
dival
cation
supplementari
factor
may
affect
titer
detail
special
signific
mention
hercinaft
discuss
individu
group
hemagglutin
virus
tcchniqu
gener
applic
quantit
viral
hemagglutin
well
describ
standard
compendia
virolog
diagnost
proccdurc
lennettc
schmidt
except
titrat
viral
hemagglutinin
correspond
antibodi
readili
adapt
microtechniqu
sever
arc
highli
reproduc
effect
substanti
economi
valuabl
diagnost
experiment
reagent
pattern
tcchniqu
one
widest
uso
otlior
approach
quantit
viral
hemagglutin
develop
particularli
influenza
virus
densitometr
procedur
first
devis
hirst
pickel
depend
rate
settl
cell
interact
viral
hcrnagglutin
partid
result
format
aggreg
read
optic
densiti
taken
given
interv
time
relat
normal
cell
suspens
without
viru
bear
direct
relationship
conccntratiori
viral
particl
evin
et
al
abl
extend
principl
establish
method
determin
absolutc
number
hemagglutin
particl
present
viru
suspens
method
base
spectrophotoqetr
measurcmcnt
thc
number
erythrocyt
dimer
viral
hemagglutinin
condit
preclud
format
larger
cell
aggreg
presenc
dimer
thc
standard
condit
use
establish
direct
rnicroscopi
worker
found
thc
convers
factor
transform
tube
dilut
hemagglutin
titer
absolut
number
hemagglutin
particl
influenza
newcastl
discas
virus
recent
photornctr
method
describ
drescher
et
al
depend
dctcrmine
highest
dilut
viru
caus
maxim
agglutin
extrapol
data
obtain
constant
number
cell
vari
dilut
viru
point
variabl
reactiv
viru
differ
sampl
erythrocyt
minim
actual
titer
calcul
mathemat
point
refer
express
hemagglutinin
concentr
unit
high
degre
reproduc
claim
method
advantag
primarili
detect
minor
antigen
variat
among
relat
strain
influenza
viru
studi
antigen
composit
influenza
viru
envelop
constitu
hemagglutinin
bcen
obtain
separ
parent
molecul
hemagglutin
directli
componentr
aye
consid
monoval
rcspcrt
hcmagglutin
activ
antigen
relat
hemagglutinin
complex
exampl
host
antigen
found
influenza
virus
whirh
propag
chicken
embryo
rnrl
discuss
subsequ
greater
detail
method
dctccting
monoval
fragment
hemagglutinin
depend
thcir
capac
combin
antihemagglutinin
therebi
block
inhibit
hemagglutin
complet
viru
hemagglutinationinhibit
block
hib
test
harbo
specif
antibodi
critic
purifi
viru
must
use
sinc
nonvir
host
tissu
fragment
may
combin
antibodi
block
hemagglutin
hemadsorpt
phenomenon
base
attach
erythrocyt
infect
cell
cultur
hemagglutinin
surfac
shelokov
et
monolay
suspect
contain
infect
cell
drain
cultur
fluid
suspens
usual
wash
guinea
pig
erythrocyt
ad
quantiti
suffici
immers
cell
reaction
take
place
almost
immedi
minut
monolay
drain
wash
cold
balanc
salt
solut
remov
unattach
cell
prepar
examin
immedi
microscop
elut
erythrocyt
occur
done
manner
hemadsorpt
may
substitut
cytopath
effect
estim
titer
unit
infect
hemadsorpt
plaqu
repres
variat
techniqu
monolay
infect
manner
plaqu
titrat
cytolyt
viru
instead
usual
solid
overlay
semisolid
overlay
eg
methyl
cellulos
agar
use
remov
end
total
incub
period
without
disturb
attach
cell
residu
trace
medium
remov
wash
prewarm
balanc
salt
solut
hemadsorpt
carri
plaqu
thu
reveal
display
dose
respons
quit
compar
infect
measur
tcid
liemadsorpt
end
point
home
et
al
offer
reliabl
mean
quantit
myxovirus
hemadsorpt
directli
quantit
lyse
attach
erythrocyt
distil
water
measur
concentr
free
hemoglobin
finter
either
fluid
semisolid
overlay
ureacyanid
aculut
ortho
pharmaceut
coipor
raritan
new
jersey
may
use
lyse
agent
render
erythrocyt
freed
tissu
cell
solubl
thu
interfer
spectrophotometr
determin
hemoglobin
convert
cyanornethemoglobin
optic
densiti
read
nm
result
express
percentag
standard
solut
cyanomcthemoglobin
sinc
discoveri
myxovir
hemagglutin
hirst
mcclelland
hare
much
learn
natur
viral
subunit
involv
reaction
well
chemistri
lreceptor
crythrocyt
n
addit
viruserythrocyt
interact
constitut
model
studi
first
stagc
viral
attach
host
cell
capabl
synthes
new
viru
extens
literatur
influenza
virus
well
review
recent
year
buzzcll
hanig
hoyl
reaction
myxovirus
red
cell
involv
two
rel
independcnt
phenomcna
namcli
adsorpt
elut
viral
compon
primarili
respons
respcctivt
ly
hemagglutinin
neuraminidasc
componcnt
viral
envelop
codcd
independ
influenza
viral
genom
recombin
strain
influenza
viru
strain
nw
serv
demonstr
hcmagglutinin
reccnt
isol
iiong
kong
differ
antigen
ap
strain
isol
prior
neuraminidas
strain
examin
antigen
ident
one
anoth
schulman
kilbourn
observabion
showcd
hemagglutinin
neuraminidas
vari
indepcnd
antigen
antibodi
enzym
werc
primari
import
protect
hong
kong
viru
also
evid
r
u
c
atud
antigen
classif
influenza
virus
must
take
account
specif
major
envelop
compon
hemagglutinin
neuraminidas
bcen
recogn
distinct
entiti
elcctron
microscop
examin
negativcli
stain
prepar
viru
disintegr
ether
deterg
separ
elcctrophoresi
column
chromatographi
densiti
gradient
centrifug
laver
valentin
disrupt
strain
influenza
viru
sodium
dodccyl
sulfat
sd
subject
clectruphorrsi
ccllulos
acet
electron
microscop
examin
elut
biolog
activ
subunit
presenc
sd
reveal
hemagglutinin
compris
rod
x
neuraminidas
appear
us
oblong
structur
x
central
attach
fiber
length
remov
sd
uccton
precipit
result
format
polym
either
subunit
mixtur
two
thc
format
copolym
result
suggest
spike
intact
virion
two
kind
correspond
respectivcli
two
independ
activ
subunit
describcd
rott
et
ae
subject
sdstreat
influenza
viru
sucros
densiti
gradient
centrifug
isol
hemagglutinin
reactiv
chicken
erythrocyt
appear
neg
stain
rodlik
structur
diamet
length
second
morpholog
form
compos
sphcrical
particl
diamet
rcactiv
guinea
pig
cell
biolog
activ
neuraminidas
hemagglutinin
isol
one
prepar
viru
treatment
separ
sephadex
residu
hemagglutinin
could
remov
neuraminidas
absorpt
chicken
erythrocyt
sediment
coeffici
hemagglutinin
subunit
neuraminidas
structur
seen
electron
microscopi
neg
stain
prepar
neuraminidas
consist
aggreg
rosett
format
central
knob
webster
n
studi
purifi
influenza
viru
treat
ether
envelop
compon
separ
nucleocapsid
electrophoret
techniqu
analyt
ultracentrifug
isol
neuraminidasehemagglutinin
complex
tend
aggreg
rosettelik
cluster
appear
compris
either
tubelik
structur
ring
attach
stalk
variat
two
form
n
biolog
activ
form
neuraminidasehemagglutinin
complex
wae
compar
size
tubular
structur
form
characterist
spike
influenza
viru
envelop
hjerten
et
al
chemic
natur
reactiv
group
viral
hemagglutinin
respons
attach
solubl
cellsurfac
glycoprotein
clear
except
peptid
involv
attach
ph
depend
therefor
may
mediat
ioniz
amino
acid
group
hemagglutinin
work
hoyl
hana
point
disulfid
linkag
activ
center
two
major
biolog
activ
influenza
viru
particl
name
hemagglutinin
neuraminidas
chemic
cleavag
ss
bond
result
inactiv
one
activ
depend
strain
viru
use
similar
observ
made
eckert
hemagglutinin
reassoci
envelop
protein
influenza
viru
hemagglutin
inhibit
mucoid
gener
independ
neuraminidas
activ
dichotomi
may
absolut
suggest
recent
studi
hoyl
indic
close
resembl
activ
site
neuraminidas
hemagglutinin
sever
strain
influenza
viru
use
reagent
react
directli
amino
acid
protein
strain
center
contain
histidin
found
appear
possess
hemagglutinin
neuraminidas
activ
conclud
histidin
essenti
neuraminidas
activ
tyrosin
could
substitut
histidin
hemagglutininact
center
includ
hemagglutinin
influenza
viru
sulfat
glycoprotein
origin
refer
host
antigen
harbo
antibodi
normal
chicken
tissu
inhibit
strain
influenza
viru
hemagglutinin
due
reaction
portion
antihemagglutinin
host
factor
viral
particl
subsequ
shown
antigen
present
liirg
quantiti
solubl
form
chorioallanto
fluid
infect
normal
chicken
embryo
could
quantit
hemagglutin
inhibit
block
hir
test
section
iiaukenc
et
lee
e
f
al
host
antigen
show
structur
similarit
blood
group
substanc
certain
keratosulf
cartilag
hauken
et
nl
meyer
et
al
rabbit
antisera
pure
substanc
contain
antihemagglutinin
react
ivc
purifi
intact
influenza
viru
particl
besid
fowl
erythrocyt
cell
mani
mammalian
speci
agglutin
infliipiiza
virus
adsorpt
appccir
rel
independ
temperatur
take
place
strain
equal
well
larg
electrostat
interact
gener
upper
ph
lower
ph
limit
ph
rang
reaction
maxim
tischer
respect
thc
molecular
basi
viral
attach
hemagglutinin
much
learn
studi
receptor
analog
prototyp
origin
describ
nonspecif
inhibitor
viral
hemagglutin
distinct
antibodi
human
serum
franci
rcccptor
analog
sincc
bccn
obtaincd
rnnni
sourc
glycoprotein
bind
preferenti
reactiv
site
viru
prevent
attach
crythrocytc
irihihitori
action
case
ubolish
follow
treatment
reagent
eg
pcriodutc
oxid
trypsin
neuraininidas
receptordestroy
enzym
vibrio
choleru
clostridiupra
perfringen
modifi
tlic
polysaccharid
moieti
alter
nana
residuc
remov
macromolecul
pttrtial
list
inhibitori
glycoprotein
includ
besid
human
anim
sera
egg
compon
urinari
mucoprotein
ovarian
cyst
fluid
mcconiurn
collocalia
mucoid
howc
ef
al
j
nncl
extract
tissu
eg
lung
erythrocyt
sever
speci
extens
studi
purifi
glycoprotein
shown
residuc
csscnlial
intcract
influenza
viru
nacetylneuramin
acid
gottschalk
b
recent
studi
shown
carbon
polyhydroxyl
side
chain
nana
involv
bind
sialoprotein
irifluerietl
viru
suttajit
winder
althollgh
inhibitor
influenza
viru
hemagglutin
contain
nana
sialoprotein
activ
inhibitor
inhibitori
potenc
glycoprotein
determin
number
neg
chargcd
termin
sialic
acid
residu
attach
simultan
complcmcntari
group
viral
surfac
attach
turn
function
number
sialic
acid
residu
avail
per
molecul
glycoprotein
degre
complementar
viral
surfac
fazeka
de
st
groth
gottschalk
basi
latter
still
unknown
relationship
molecular
size
sialic
acid
content
inhibitori
activ
recogn
among
number
natur
occur
inhibitor
influenza
viru
hemagglutin
springer
et
al
relationship
also
demonstr
artifici
serum
orosomucoid
nativ
state
weak
inhibitor
polym
produc
heat
control
condit
molecular
weight
greater
weight
basi
found
much
potent
inhibitor
monomer
form
whitehead
winzler
inhibitori
activ
lost
treatment
v
cholera
neuraminidas
concord
result
obtain
orosomucoid
polymer
crosslink
acetaldehyd
morawiecki
lisowska
polym
molecular
weight
excess
show
activ
approxim
greater
monom
filament
form
heatpolymer
orosomucoid
found
activ
certain
strain
influenza
viru
globular
form
macromolecul
barclay
et
al
observ
suggest
multipl
reactiv
site
viral
particl
might
reactiv
sialic
residu
linear
disposit
convolut
molecul
thu
account
greater
inhibitori
effici
chain
polym
ball
howev
hemagglutin
viral
subunit
equal
sensit
inhibit
two
morpholog
form
orosomucoid
therefor
seem
factor
simpli
spatial
configur
nana
residu
must
essenti
interact
viral
hemagglutinin
heatlabil
inhibitor
unrel
antibodi
complement
found
mani
anim
sera
c
chu
factor
p
inhibitor
inactiv
period
neuraminidas
either
bacteri
viral
origin
requir
calcium
ion
activ
inactiv
trypsin
properti
suggest
antivir
activ
involv
peptid
rather
glycosid
linkag
analog
erythrocyt
receptor
influenza
viru
may
exist
involv
termin
nana
residu
p
inhibitor
seem
greater
activ
b
strain
influenza
viru
hoyl
third
type
nonspecif
inhibitor
gamma
inhibitor
present
normal
anim
sera
particularli
hors
guinea
pig
hors
serum
inhibitor
glycoprotein
distinct
antibodi
highli
activ
strain
influenza
viru
littl
activ
b
strain
stabl
heat
neutral
hemagglutinin
well
infect
neutral
effect
ascrib
unusu
avid
strain
viru
complex
receptor
group
glycoprotein
firm
inhibitorviru
union
may
also
due
incomplet
receptor
dcstruction
viral
enzym
consequ
failur
viru
inhibitor
dissoci
fraction
structur
studic
levinson
et
al
hors
serum
inhibitor
show
compris
two
activ
siibstitu
polysaccharid
moieti
name
well
nana
former
rcprcsent
group
activ
influenza
viru
latter
residu
reactiv
recent
b
isol
accord
interpret
thc
fact
inhibitor
sensit
viral
ncuraminidas
trealrncnt
mild
alkali
n
addit
metaperiod
treatment
enhanc
inhibitori
activ
b
viru
sinc
type
enhanc
encount
strain
influenza
viru
isol
prior
postul
chang
relat
natur
antigen
modif
emerg
time
find
suggest
structur
nana
might
play
determin
role
inhibit
viral
hernagglutinin
strain
influenza
obtain
isol
viru
pandem
whicli
distinguish
either
sensit
insensit
hors
serum
gamma
inhibitor
reactiv
antibodi
parallcletl
receptor
destruct
serum
inhibitor
erythrocyt
choppin
tamm
avid
strain
glycoprotein
substrat
explain
failur
substrat
hydrolysi
henc
failur
viru
liber
complex
choppin
ttimm
ptirnllel
ohserv
report
indic
avid
strain
still
abl
agglutin
fowl
cell
rcrnoval
receptor
influenza
virus
treatment
rde
either
bacteri
viral
moreov
avid
strain
elut
incomplctcli
ncurnminidasctr
erythrocyt
find
taken
mcan
avid
strain
rcceptor
uncov
ncuraminidas
period
treatment
diff
ere
qualit
nonavid
strain
influenza
viru
takatsi
et
al
assum
cornhin
irifluenza
virus
glycoprotcin
variou
sourc
depend
forc
molecular
requir
respons
viral
attach
glycoprotein
receptor
surfac
erythrocyt
describ
earlier
section
vr
solubl
viru
receptor
substanc
human
erythrocyt
thc
oligobaccharid
residu
requir
viral
attach
moreov
nana
erythrocyt
termin
bound
clettvcd
neuraminidas
loth
bacteri
viral
fiidirig
cite
respect
avid
strain
viru
suggest
prcscrice
erythrocyt
determin
inhibitori
group
includ
nana
substanti
hand
presenc
differ
substitut
neuramin
acid
bccn
entir
cxclude
import
sialopeptid
split
erythrocyt
action
trypsin
poor
inhibitor
hemagglutin
parent
matcrial
howev
recogn
macramoleculc
monomer
molecular
weight
potent
inhibitor
increas
potcnci
polymer
springer
et
al
thcre
evid
show
remov
sialopeptid
trypsin
result
complet
remov
nana
erythrocyt
still
capabl
hemagglutin
influenza
viru
winzler
henc
portion
peptid
backbon
may
involv
interact
includ
proxim
portion
oligosaccharid
side
chain
solubl
sialic
acidcontain
fraction
erythrocyt
membran
whether
deriv
butanol
pyridin
extract
tabl
sever
order
magnitud
less
potent
vr
viral
inhibitor
may
explain
fact
fraction
mixtur
activ
less
aggreg
glycoprotein
inact
protein
certainti
frequenc
distribut
necessari
receptor
configur
sialoprotein
fraction
glycoprotein
purifi
phenol
method
adsorpt
viru
erythrocyt
suspens
caus
aggreg
fragil
lattic
settl
form
characterist
agglutin
pattern
bottom
tube
titrat
well
plate
visibl
reaction
follow
elut
intact
viral
particl
reaction
mixtur
brought
ph
elut
influenza
viru
initi
recogn
enzymat
natur
hirst
known
due
action
neuraminidas
viral
envelop
complet
influenza
viral
particl
elut
crythrocyt
surfac
may
vari
strain
strain
basic
mechan
consid
case
elut
viral
particl
accompani
releas
nana
receptor
site
similarli
interact
solubl
analog
viral
neuraminidas
effect
degrec
dissoci
vari
strain
intim
structur
studi
orosomucoid
indic
prosthet
group
necessari
interact
influenza
viru
includ
oligosaccharid
side
chain
link
oglycosid
serin
threonin
gottschalk
nana
occupi
termin
nonreduc
posit
aketosid
linkag
nacetylgalactosamin
latter
bond
viral
neuraminidas
act
free
nana
glycoprotein
inhibitor
graham
gottschalk
carubelli
et
al
gottschalk
polyhydroxi
side
chain
nana
must
intact
maximum
activ
cneym
take
place
sutttijit
winzler
n
gcnerul
complet
elut
crythrocyt
appear
invers
proport
avid
glycoprotein
inhibitor
exemplifi
reaction
struin
influenza
viru
gamma
inhibitor
hors
serum
cite
carlier
n
studi
low
rnolecular
wcight
oligosaccharid
substrat
ncuramiiiidas
enzym
ti
chaleru
classic
rde
shown
hydrolyz
ketosid
linkag
wherca
viral
enzym
attach
thc
bond
although
cornpourid
abl
bind
viral
enzyn
latter
act
slightli
releas
nana
drzeniek
suggest
enzym
may
rolc
albeit
limit
bind
thc
virtil
particl
cell
receptor
materi
probabl
linkag
cxibt
erythrocyt
deduc
studi
alkali
labil
tetrasaccharid
obtain
borohydrid
reduct
stromal
sialopcptidc
latter
deriv
r
p
n
treatment
either
viru
receptor
substtinc
vr
crythroc
yte
tabl
winder
demonstr
adsorpt
elut
influenza
viru
electrophoret
mobil
erythrocyt
greatli
reduc
concert
resist
reagglutin
freshli
ad
viru
hanig
stone
arid
ada
cook
et
al
treatment
rde
v
cholera
trypsin
pcriodut
achiev
result
earli
observ
subsequ
confirm
extend
urc
readili
explttiricd
cucli
insttiric
rcmovul
sialic
acid
residu
whether
nana
alon
part
sialopeptidc
fragment
predomiriuntli
neg
charg
erythrocyt
physiolog
ph
bc
ascrib
entir
ioniz
frce
coogroup
sialic
acid
similarli
electrophoret
mobil
purifi
vk
human
rbc
greatli
reduc
follow
reaction
influenza
viru
remov
sialic
acid
howe
et
al
resid
chang
electrophorct
mobil
reinov
nana
residu
human
erythrocyt
either
viral
bacteri
ncuraminidas
effect
strike
chang
immunolog
reactiv
cell
concern
sever
specif
n
blood
group
antigen
inactiv
inyxovirus
act
either
whole
cell
purifi
erythrocyt
glycoprutcin
bcwririg
thcsc
determin
forssman
heterophil
antigen
includ
associ
infecti
mononucleosi
arid
specif
relut
broadli
reactiv
serum
panagglutinin
phytohernagglutinin
subject
antigen
alter
erythrocyt
myxovirus
solubl
cnzymc
revicwcd
elsewher
springer
drzeniek
paramyxoviru
group
set
apart
orthomyxovirus
influenza
virus
includ
virus
mump
newcastl
diseas
parainfluenza
subgroup
compris
member
n
contrast
influenza
virus
paramyxovirus
capabl
lyse
erythrocyt
sever
speci
fuse
cell
cultur
form
polykaryon
neither
hemolysi
cell
fusion
caus
exogen
appli
viru
bore
relat
virul
sever
strain
ndv
kohn
fuch
n
contrast
polykaryocytosi
induc
activ
infect
chick
embryo
fibroblast
endogen
fusion
correl
virul
sever
strain
ndv
chicken
embryo
reev
alexand
moreov
fuse
capac
avirul
strain
enhanc
blockad
cellular
rna
synthesi
inhibit
protein
synthesi
pfluorophenylalanin
cyclohexamid
result
parallel
inhibit
fusion
virul
strain
find
suggest
protein
synthesi
requir
fusion
occur
cytopatholog
induc
avirul
strain
relat
failur
viral
matur
releas
intracellular
accumul
viral
product
reev
post
molecular
basi
cell
fusion
whether
exogen
endogen
still
larg
unknown
howev
true
viral
hemolysi
paramyxovirus
hemagglutin
erythrocyt
avian
well
number
mammalian
speci
influenza
group
viral
hemagglutinin
situat
spike
viral
envelop
close
associ
viral
neuraminidas
hemagglutin
occur
strain
paramyxovirus
wide
rang
ph
optim
tischer
presum
much
mechan
influenza
viru
receptor
erythrocyt
involv
prove
capac
influenza
virus
inactiv
receptor
paramyxovirus
vice
versa
trypsin
v
cholera
enzym
equal
effect
regard
receptor
destruct
instanc
associ
releas
diffus
nana
strain
paramyxovirus
particularli
adapt
laboratori
passag
rel
insensit
alpha
franci
type
hemagglutin
inhibitor
nonetheless
capabl
split
nana
receptor
analog
well
purifi
vr
howe
morgan
one
except
appear
purifi
ovin
alglycoprotein
report
inhibit
ndv
hemagglutin
high
titer
independ
viral
enzym
activ
campbel
e
al
paramyxovirus
elut
erythrocyt
surfac
lower
effici
influenza
virus
virus
activ
hemolyt
shown
elut
neutral
hcmolyz
temperatur
ahov
c
ndv
mump
sendai
adsorb
formalin
fowl
erythroryt
elut
ki
iov
pt
nl
iwu
elut
viru
may
show
rel
increas
hcmaggliit
inin
titer
decreas
infect
effect
due
disrupt
frwgmentat
viral
particl
john
fulgin
viral
heniolysi
first
describ
mump
viru
morgan
et
chu
morgan
ndv
kilham
arid
somewhat
recent
scndai
viru
sato
type
pnrrtinflurnza
viru
ticrmodsson
et
nl
h
r
rxnct
mechan
mediat
viral
llcmolysi
remain
c
eliicid
howev
sever
fact
estahlish
throw
light
phenomenon
hemolysi
occur
intact
viral
particl
larg
subunit
requir
shown
sendai
ndv
sagik
lcvine
sokol
nl
heterogen
ndv
particl
respect
hemolyt
activ
demonstr
sokol
incomplet
sendai
viru
less
hemolyt
complet
viru
sokol
et
al
hut
shown
sonicnt
infect
viru
progress
inactiv
licmolysi
ultim
elimin
hemagglutin
particl
mere
reduc
helow
certnin
rang
hosaka
accord
wit
h
earlier
find
subunit
sendai
viru
ohtaincd
cthrr
disrupt
thr
viral
cnvelopr
nonhemoiyt
sokol
et
nl
respect
cell
surfwc
clear
receptor
requircd
hrmolysi
hemagglutin
sinc
viru
must
attach
order
hemolyz
origin
shown
rnrimp
viru
l
chu
morgan
sinc
demonstr
scnd
ti
viru
sokol
tnd
ncwatei
accordingli
intibodi
purifi
viru
receptor
rubstanc
prevent
tjhc
agglutin
well
lysi
human
group
erythrocyt
sendai
viru
lwnnlytic
properti
invcrscli
proport
capac
given
strain
elut
tlic
red
crll
surfac
demonstr
ndv
isagik
levin
obscrvat
suggest
dcgree
contact
ie
rcsultant
particl
size
avid
cell
receptor
might
critic
import
electron
microscop
etarnin
crythrocyt
e
ghost
lyse
scndwi
viru
gave
n
clue
el
natur
contact
concentr
sendai
viru
adsorb
erythrocyt
caus
invaginatiom
plasma
mcmhrane
aftcr
elev
tcmperaturr
c
plasma
membran
ecnin
fuscd
viral
ciivclopc
ccll
lysi
followccl
accompani
rapid
total
loss
hrmoglobin
extracellular
space
deplet
membran
nana
concomitantli
ruptur
virion
occurreti
relcasc
nuclcounpsid
howe
hforgan
tt
appear
thc
viral
particl
join
erythrocyt
initi
agglutin
reaction
torn
apart
result
sheer
forc
engend
rapid
cell
iysi
recent
shown
fusion
human
erythrocyt
occur
cell
agglutin
viru
pack
light
centrifug
undisturb
pellet
brought
largc
stabl
polymembran
retain
appreci
amount
hemoglobin
thu
form
viral
envelop
compon
recogn
morpholog
ground
howev
free
nucleocapsid
filament
seen
cytoplasm
fuse
erythrocyt
freezeetch
techniqu
demonstr
smooth
plaquelik
area
form
obliter
redistribut
normal
wellord
numer
intramembran
particl
bachi
howe
unpublish
rearrang
intramembran
particl
result
viral
action
reminisc
regroup
effect
proteolyt
enzym
constitut
basi
propos
sialoglycoprotein
receptor
expos
cell
surf
ace
associ
intramembran
particl
hemagglutinin
well
hemoli
sin
trypsin
sensit
suggest
peptid
residu
viral
envelop
involv
neurath
fontang
et
al
n
addit
hemolyt
properti
sendai
viru
may
host
depend
express
sinc
viru
grown
mous
lung
cell
cultur
nonhemolyt
wherea
viru
chick
embryo
strongli
hemolyt
ishida
homma
matsumoto
maeno
n
sum
appear
sendai
viru
probabl
also
paramyxovirus
red
cell
lysi
complex
interact
intact
virion
larger
subunit
cell
surfac
factor
known
oper
requir
firm
adsorpt
hemagglutinin
sialoprotein
cell
receptor
readili
effect
suffici
area
contact
intact
virion
larger
envelop
fragment
cell
receptor
site
temperatur
p
h
depend
suggest
form
enzymat
activ
involv
effect
initi
breach
integr
cell
membran
result
either
lysi
individu
cell
virusco
cell
remain
close
apposit
one
anoth
fusion
rel
restrict
loss
hemoglobin
latter
instanc
must
assum
increas
permeabl
membran
transient
durat
extent
limit
egress
hcmoglobin
except
porcin
kidney
cell
hosaka
chicken
embryo
suscept
host
yield
hemolyt
viru
possibl
consid
hostderiv
enzym
factor
neurath
neurath
lysolecithin
rebel
et
al
adsorb
otherwis
attach
viru
may
somehow
contribut
hemolyt
activ
definit
confirm
possibl
lack
jikewis
relationship
hernolysin
report
present
normal
chorioallanto
membran
liernolyt
action
sendai
viru
clear
neurath
hemadsorpt
phenomenon
account
viral
antigen
particularli
hcinagglutinin
present
thc
surfac
infect
cell
hcforc
releas
virion
bud
membran
shown
electron
microscop
studi
use
ferritinlabel
antibodi
matur
relerts
paramyxoviru
particl
accompariicd
nccumul
rihonuclcoprotcin
strand
segment
membran
alter
display
antigen
specif
ident
viral
envelop
similarli
viral
antigeri
replac
normal
cell
membran
antigen
cours
influenza
viru
infect
ducnguyen
ef
nl
presenc
viral
hemagglutinin
altcrcd
membran
site
demonstr
electron
microscop
examin
mump
viru
heinadsorpt
took
place
surfac
infect
cell
even
matur
releas
virion
ducnguyen
prcscnce
neuraminidas
also
deirionstr
monolay
earli
hour
infect
influenza
viru
releas
progeni
viru
viral
enzym
activ
associ
membran
well
cell
sap
releascd
freea
tirid
thaw
kendal
und
apostolov
pseudomyxoviru
group
cvnprise
agent
mcaslc
rubeola
canin
distemp
arid
rindcrpest
nicdipest
group
lmagawa
reserv
respiratori
syncyti
rs
viru
group
resembl
larg
pararnyxovirus
morpholog
certain
biolog
properti
complet
virion
approxim
size
paramyxovirus
contain
rna
helic
symmetri
envelop
projcction
characterist
myxovirus
envelop
ethcr
sensit
thcrebi
assum
essenti
lipid
differcric
parnmyxovirus
howev
strike
consist
resembl
arid
concern
import
properti
envelop
none
pseudomyxovirusc
possess
neuraminidas
measl
one
hemagglutin
extens
literatur
biolog
measl
viru
well
review
waterson
lieinagglutinin
measl
properti
viral
envelop
llsoiubl
noninfect
hemagglutin
particl
cultur
measl
viru
recognizcd
subunit
fragment
envelop
accumul
cultur
cytopatholog
progress
refer
larg
hemagglutinin
infect
noninfect
hemagglutinin
small
hemagglutinin
respect
e
c
j
norrbi
et
al
larg
hemagglutinin
character
either
intact
infect
viru
virion
undergon
partial
disorgan
henc
longer
infect
retain
physic
properti
particl
small
hemagglutinin
noninfect
rnp
core
vari
densiti
rel
wide
rang
certain
proport
small
hemagglutinin
seen
high
densiti
particl
characterist
rosett
appear
treatment
viru
tween
ether
e
norrhi
funahashi
kitawaki
result
convers
hemagglutinin
latter
form
time
substanti
increas
hemagglutinin
titer
prepar
ether
disrupt
viral
envelop
consequ
reduct
hemagglutinin
titer
function
tween
protect
smaller
protein
subunit
denatur
henc
preserv
activ
tween
hemagglutinin
sensit
inhibit
antibodi
thercfor
constitut
improv
crude
cultur
fluid
reagent
use
hemagglutinationinhibit
test
treatment
viru
sodium
deoxychol
sd
result
disintegr
viral
particl
allow
better
separ
nucleocapsid
small
rosett
hemagglutinin
achiev
tween
treatment
reason
sd
would
appear
satisfactori
reagent
separ
nonhemagglutin
complementfix
antigen
nucleocapsid
envelop
constitu
norrbi
small
hemagglutinin
also
describ
found
lower
buoyant
densiti
other
low
densiti
particl
lack
rna
capabl
hemolysi
caus
earli
cpe
latter
probabl
phenomenon
earli
rapid
fusion
produc
applic
high
titer
measl
viru
cell
monolay
cascardo
karzon
charact
cytopatholog
viral
progeni
result
infect
monolay
measl
viru
found
vari
multipl
infect
viru
passag
undilut
cultur
fluid
caus
format
incomplet
viru
consist
antigen
high
hemagglutin
hemolyt
titer
rel
low
infect
wherea
viru
passag
high
dilut
result
product
viru
almost
hemagglutinin
hemolyt
activ
high
infect
e
norrbi
e
al
hemagglutinin
discuss
refer
virion
subunit
directli
deriv
adsorb
readili
erythrocyt
presenc
minim
concentr
monoval
polyval
cation
c
howe
rj
lee
none
made
elut
found
addit
salt
ammonium
sulfat
measl
viru
pool
enhanc
hemagglutin
titer
schluederberg
degre
enhanc
depend
relutivc
concentr
particl
show
increas
hcmagglutinatiun
titcr
high
salt
concentr
moreov
sonic
prepar
alter
ratio
toward
higher
titer
evid
suggest
chttnge
rcfcrabl
physic
disintegr
viral
cnvelopc
sonic
measl
viru
prescnc
ammonium
sulfat
also
sensit
inhibit
antibodi
untreat
viru
class
particl
averag
sedirncntatiori
coefici
smaller
hemagglutinin
previous
describ
demonstr
extract
cell
infect
measl
viru
schlucdcrberg
nakamura
particl
contrast
normal
hemagglutinin
includ
cnhanccablc
hyperton
salt
strictli
depend
presenc
polyval
anion
adsorpt
agglutin
erythrocyt
agglutin
activ
greater
ph
ph
increas
elev
temperatur
moreovcr
saltdepend
agglutinin
sda
adsorpt
lo
erythrocyt
hyperton
solut
could
elut
isoton
salin
antigen
ttrialysi
reveal
clearli
relat
sda
measl
infect
data
suggest
particl
might
repres
virusspecif
envelop
precursor
envelop
comporierit
includ
releas
viral
progeni
trypsin
inactiv
hernagglutinin
suggest
protein
involv
interact
erythrocyt
viruscod
protein
surfacc
infect
cell
may
held
arcount
hemadsorpt
kc
demonstr
nionolay
infect
measl
viru
limit
electron
microscop
observ
phenomenon
baker
ef
al
erythrocyt
found
close
contour
fit
infcctecl
cell
mirrovilli
iiitact
viral
particl
rare
recogn
moreov
none
morpholog
chang
characterist
cell
infect
paramyxovirus
segment
cell
membran
convert
antigen
specif
idellt
viral
crivclopc
find
suggest
mechan
measl
viru
hemadsorpt
henc
hemagglutin
free
viral
compon
differ
perhap
significantli
paramyxovirus
concord
last
supposit
evid
prcsent
suggest
erythrocyt
receptor
also
differ
orthomyxovirus
treatment
erythrocyt
formalin
inactiv
receptor
measl
viru
leav
intact
influenza
viru
peri
chani
neuraminidas
whether
myxovir
bacteri
fail
inactiv
measl
viru
receptor
interest
connect
purifi
vr
prepar
rhesu
erythrocyt
phenol
method
inhibit
measl
hemagglutin
howe
unpublish
result
n
one
studi
rhesu
erythrocyt
treat
vibrio
cholera
neuraminidas
display
enhanc
agglutin
measl
viru
certain
adenmirus
qv
chymotrypsin
hand
reduc
abolish
capac
rhesu
erythrocyt
agglutin
virus
tischer
taken
togeth
fact
suggest
receptor
activ
associ
primarili
protein
erythrocyt
surfac
rather
carbohydr
residu
anim
sera
contain
nonspecif
measl
hemagglutinin
inhibitor
probabl
lipoprotein
remov
adsorpt
kaolin
treatment
serum
heparinmncl
feldman
hemolyt
activ
measl
viru
clearli
relat
viral
envelop
also
size
hemagglutin
particl
presum
erythrocyt
receptor
involv
sinc
attach
hemagglutinin
requir
hemolysi
condit
ph
temperatur
parallel
hemagglutin
infect
prerequisit
hemolysi
clear
size
hemagglutin
particl
critic
thu
intact
virion
larg
noninfect
hemagglutinin
small
hemagglutinin
low
densiti
hemolyt
three
also
capabl
rapid
cell
fusion
waterson
hemagglutin
unit
smaller
size
nonhemolyt
also
hemagglutinin
deriv
tween
extract
viru
would
thu
seem
parallel
relat
particl
size
hemolyt
activ
hemolyt
action
sendai
newcastl
diseas
virus
parallel
suggest
result
studi
thc
inactiv
measl
viru
hemagglutinin
hemolysin
neurath
norrbi
compound
react
specif
protein
result
similar
report
sendai
viru
hemagglutinin
hemolysin
neurath
point
aromat
amino
acid
critic
role
mediat
activ
peptid
viral
envelop
paramyxovirus
exact
mechan
measl
viru
hemolysi
remain
elucid
adenovirus
divis
least
three
major
group
depend
capac
agglutin
erythrocyt
sever
mammalian
speci
rosen
signal
discoveri
afford
addit
basi
classif
also
point
import
biolog
c
houe
l
lee
differ
sever
group
tlicsc
differ
explain
part
rcccnt
elucid
structur
function
sdenovirsl
cttpsid
compon
origin
recogn
antigen
specif
pereira
yereira
figucircdo
refer
summari
tahlc
tabl
show
divis
tlicsc
group
base
complet
partial
agglutin
rhcsu
rat
human
erythrocyt
group
subdivid
accord
reactiv
erythrocyt
addit
speci
mous
guinea
pig
grivet
wadel
variou
morpholog
subunit
associ
hemagglutin
otlicr
properti
viral
capsid
identifi
arid
form
basi
nomenclaturc
wide
accept
ginsbcrg
ct
al
n
origin
design
complet
hemagglutin
referrcd
smooth
uniform
pattern
produc
appropri
condit
given
strain
n
group
partial
pattern
produc
direct
action
viru
prepar
seen
rs
button
midst
agglutin
cell
pattern
render
complet
uniform
addit
hcterotyp
antibodi
ruben
pereira
figueircdo
strain
show
littl
hcmagglutin
could
made
agglutin
proccdurc
complet
partial
forin
agglutin
inhibit
typespecif
antibodi
princip
mediat
hcmagglutin
thc
fiber
antigen
tlie
intact
virion
well
variou
subunit
recover
solubl
hemagglutinin
fraction
infect
cell
tlie
function
standpoint
thcsc
subunit
may
either
complet
bior
multival
incomplet
monoval
hemagglutinin
complet
hcmagglutinin
intact
virion
sever
structur
form
solubl
hemagglutinin
nanicli
dodecon
penton
intact
fiber
clirncr
either
penton
fiber
singl
penton
fiber
incomplet
hernagglutinin
although
monoval
capabl
adsorb
thc
crythrocytc
surfac
shown
capac
fiber
antigen
inhibit
agglutin
rat
human
cell
purifi
virion
wadel
incomplet
hemagglutinin
arc
render
bival
combin
heterospecif
antibodi
latter
direct
either
vertex
capsomer
penton
antigen
proxim
portion
fiber
wig
antigen
corriplex
fiber
antigen
increas
length
one
serotyp
anoth
perhap
signific
gener
fiber
antigen
group
virus
longest
amen
interact
heterotyp
antibodi
format
complet
agglutinin
e
norrbi
also
appear
sever
class
capsid
subunit
produc
greatest
abund
cell
infect
group
virus
action
socal
reccptor
modifi
factor
origin
found
cell
cultur
group
virus
kasel
et
al
kasel
huber
probabl
explain
competit
inhibit
complet
rat
human
cell
agglutinin
fiber
antigen
elabor
group
group
virus
wadel
type
virus
produc
dodecon
solubl
hemagglutinin
evid
indic
distal
knob
adenoviru
fiber
respons
interact
virion
solubl
hemagglutinin
erythrocyt
fiber
knob
also
locu
attach
hemagglutinininhibit
antibodi
nontermin
arginin
residu
viral
capsid
presum
locat
fiber
glutam
aspart
carboxyl
acid
group
red
cell
membran
protein
requir
revers
interact
adenoviru
type
erythrocyt
neurath
et
al
interest
treatment
human
cell
rde
iibrio
cholera
well
influenza
viru
reduc
consider
thc
capac
cell
agglutin
type
adenovirus
likewis
adenoviru
adsorb
normal
human
e
ythro
yte
could
elut
rde
appar
type
uniqu
among
adenovirus
thu
far
studi
characterist
suggest
correspond
receptor
differ
type
wadel
adenovirus
classifi
group
give
complet
agglutin
rat
erythrocyt
certain
group
virus
howev
also
agglutin
rhesu
cell
investig
sever
type
show
portion
inonkci
cell
hemagglutinin
wt
associ
virion
type
arid
could
riot
separ
thc
respcctiv
agglutinin
rat
cell
hand
solubl
rat
cell
agglutinin
type
separahl
one
anoth
basi
buoyant
densiti
diffcr
affinit
monkey
cell
tabl
wigand
stohr
addit
monkey
cell
agglutinin
resist
rat
cell
agglutinin
trypsin
follow
lrclttirig
c
furthcr
indic
divers
physic
andor
chemic
configur
hemagglutinin
divers
reflect
also
vari
affin
typespecif
antibodi
human
anim
sera
contain
nonspecif
inhibitor
hemagglutin
occasion
titer
suffici
interfer
detect
specif
antibodi
rosen
schmidt
et
al
nonspecif
inhibitor
may
rcinov
adsorpt
kaolin
inactiv
pseudomom
filtrat
schmidt
et
nl
latter
treatment
thought
remov
less
antibodi
tlian
kaolin
particularli
import
consider
scra
contain
low
antibodi
titer
thc
result
may
achiev
adsorpt
mann
et
al
appear
differ
type
inhibitor
adenoviru
type
found
fraction
serum
also
adsorb
kaolin
thc
charactcrist
mucopolysaccharid
molecular
weight
orosorriucoid
albumin
electron
microscop
evid
suggest
floccul
whole
viral
particl
purifi
inhibitor
latter
attach
directli
hemagglutin
site
virion
shortridg
biddl
suggest
evid
chemic
natur
adenoviru
hemagglutinin
receptor
come
direct
analysi
rhesu
erythrocyt
ghost
neurath
et
al
shown
phenol
nbutanol
potassium
period
treatment
membran
render
incap
inhibitori
activ
adenoviru
type
wherea
rde
effect
although
elimin
receptor
influenza
viru
inactiv
adenoviru
receptor
effect
treatment
trypsin
chymotrypsin
papain
pronas
ficin
find
taken
evid
proteinac
natur
receptor
consid
involv
glycoprotein
sinc
origin
descript
hemagglutin
japanes
b
enceph
viru
sabin
buescher
properti
found
associ
mani
arbovirus
recogn
certain
arbovirus
group
b
cell
cultur
detect
hemadsorpt
buckley
hemagglutin
hemagglutin
inhibit
form
basi
group
virus
casal
brown
clark
casal
assay
goos
cell
use
prefer
newli
hatch
chick
cell
method
use
prepar
hemagglutin
antigen
refin
recent
year
although
still
base
rel
empir
observ
sourc
antigen
often
suckl
mous
brain
group
c
strain
mous
sera
ardoin
et
al
casal
whitman
basic
procedur
involv
extract
homogen
infect
brain
tissu
aceton
presenc
sucros
function
latter
protect
viru
action
aceton
aceton
presum
separ
viral
particl
normal
brain
lipid
interfer
attach
hemagglutinin
erythrocyt
aqueou
extract
brain
tissu
usual
lower
hemagglutin
titer
due
presenc
lipid
recent
studi
pedreira
et
al
endeavor
compar
util
sever
prepar
method
demonstr
simpl
genetron
extract
suckl
mous
brain
yield
antigen
compar
deriv
sucroseaceton
extract
hemagglutin
titer
group
c
virus
enhanc
sonif
certain
instanc
trypsin
treatment
ardoin
et
al
final
antigen
prepar
though
partial
inactiv
still
retain
substanti
measur
infect
henc
must
handl
due
precaut
condit
hemagglutin
arbovirus
perform
critic
thu
group
virus
optim
ternperatur
optim
ph
correspond
valu
meinber
group
b
ph
casal
brown
spontan
elut
certain
group
virus
may
shown
occur
outsid
pii
rang
optiiri
fur
lienugltitinatiori
salmincn
elut
detect
alter
erythrocyt
surfac
sinc
erythrocyt
viru
elut
fulli
capabl
absorb
viru
othrr
type
rde
treatment
red
cell
fail
affect
aggliitin
certain
arbovirus
eastern
western
equin
encephalomyel
karabstso
thu
indic
thitt
receptor
involvc
nana
differ
charact
andor
disposit
group
b
receptor
suggest
find
trypsin
chymotrypsin
papain
iriactivatcd
group
b
virus
group
virus
respect
hemagglutinin
infect
evid
indic
hemagglutinin
group
viru
includ
protein
viral
capsid
cheng
numher
investig
direct
toward
establish
analog
lipid
lipoprotein
one
hand
llreceptor
substanc
present
erythrocyt
surfac
thu
serum
lipoprotein
shown
havc
inhibitori
effect
srboviru
hemagglutin
remov
absorpt
kaolin
mean
often
necessari
order
discov
presenc
antibodi
clark
fraction
extiactahl
ox
brain
rich
phosi
liotitlglinofiitol
also
shown
bind
hcmagglutin
urbovirus
preferenti
thu
inhibit
hcmagglutin
frischniggemey
led
infer
receptor
erythrocyt
werc
includ
lipid
suggest
evid
also
becn
sdrluccd
direct
assessriierit
hemagglutin
inhibit
human
red
cell
phospholipid
fraction
felect
arbovirus
group
b
porterfield
row
b
virus
inhibit
lipoprotein
either
serum
r
erythrocyt
singl
group
viru
test
recent
cxploir
chemic
natur
erythrocyt
receptor
rcprcscntativ
group
b
virus
involv
assay
hemagglutin
inhibit
test
crude
goos
red
cell
stromata
extract
syucou
ether
inhibitori
materi
final
uscd
contain
detect
sialic
acid
trace
hexos
substanti
phospholipid
protein
nicoli
evid
suggest
similar
variou
lipid
inhibitor
actual
receptor
site
erythrocytr
undermin
sever
consider
phosphotidylinositol
present
red
cell
membran
anion
charact
erythrocyt
surfac
ascrib
wholli
termin
bound
nana
extens
studi
undertaken
mixtur
standard
lipid
show
suitabl
steric
arrang
necessari
aqueou
solut
interact
arbovirus
take
place
gorman
admit
leabt
possibl
lipidlipid
interact
justifi
assumpt
cell
receptor
lipid
even
requir
lecithin
cholesterol
interact
viral
hemagglutinin
chemic
natur
receptor
arbovirus
thu
remain
obscur
although
attract
possibl
still
remain
hemagglutin
proteinprotein
interact
viral
capsid
membran
involv
membran
polysaccharid
uncertain
reovirus
origin
design
echo
virus
separ
group
basi
larger
size
characterist
cytopath
effect
differ
enterovirus
reovirus
found
mani
speci
besid
man
regardless
speci
separ
three
distinct
serotyp
base
hemagglutin
inhibit
reaction
rosen
human
erythrocyt
agglutin
three
type
howev
also
react
bovin
erythrocyt
somewhat
higher
titer
agglutinin
neither
strictli
ph
temperatur
depend
take
place
equal
well
ph
rang
elut
variabl
nonenzymat
natur
human
erythrocyt
receptor
reoviru
unaffect
vibrio
cholera
neuraminidas
howev
bovin
te
receptor
tyfe
inactiv
enzym
egger
et
al
gomato
tamm
suggest
may
differ
receptor
type
type
relat
presenc
nana
residu
trypsin
reduc
agglutin
human
erythrocyt
three
type
lerner
et
al
sinc
human
erythrocyt
bear
determin
blood
group
ie
cell
group
ab
reactiv
three
serotyp
cell
group
b
brubak
et
al
blood
group
substanc
may
implic
reoviru
receptor
howev
appear
main
reactiv
site
red
cell
protein
sensit
trypsin
chymotrypsin
insensit
certain
carbohydratesplit
enzym
borohydrid
lerner
miranda
would
minim
role
polysaccharid
compon
demonstr
sensit
trypsin
chymotrypsin
indic
essenti
peptid
linkag
aromat
amino
acid
involv
receptor
activ
hand
preincub
type
reovirus
sodium
borohydrid
well
carbohydras
particularli
beta
glucosaminidas
substanti
reduc
agglutin
potenc
find
suggest
polysaccharici
residu
virion
might
essenti
hemagglutin
action
nacetylglucosamin
report
inhibitori
agglutin
human
cell
three
type
reoviru
inhibit
prove
bo
due
attach
sugar
virion
rather
combin
surfac
erythrocyt
interpret
suggest
nacetylglucosamin
red
cell
surfac
might
involv
union
capsid
glycoprotein
howev
oligosaccharid
residu
yet
definit
recogn
form
part
reovir
capsid
hemagglutin
properti
complet
incomplet
coreless
particl
papadirnitri
sh
group
virion
essenti
conclus
base
find
treatment
viru
type
pcholoromercuribenso
pcmb
inactiv
hemagglutinin
infect
former
reactiv
thiol
compound
eg
reduc
glutathion
gsh
gomato
tamm
remov
cttpsid
layer
proteolyt
enzym
result
increas
infect
three
typc
reoviru
hemagglutin
activ
retain
ensymetr
viru
electron
microscop
examin
thcse
capsidless
particl
reveal
presenc
spikelik
compon
protrud
subcapsid
layer
thought
contain
hemagglutinin
spendlov
et
al
exact
natur
bond
viral
hemagglutinin
receptor
erythrocyt
remain
unidentifi
howev
said
sh
group
virion
arc
nccebsari
reaction
one
kind
receptor
type
may
glycoprotein
two
type
receptor
protein
without
essenti
sh
group
sinc
pretreat
crythrocytc
pcmb
effect
hcmagglutin
virus
nonspecif
hemagglutin
inhibitor
show
characterist
parallel
erythrocyt
receptor
thu
type
reoviru
found
bind
ovomucin
inhibitor
present
iri
variou
anim
sera
inactiv
rde
gomato
tamm
likewis
salivari
muciri
shown
bind
properti
lerner
et
al
arid
inactiv
rde
find
substanti
affin
reovirus
glycoprotein
except
analog
gave
rel
littl
direct
inform
regard
chemic
natur
erythrocyt
receptor
group
nonspecif
serum
inhibitor
reoviru
herriagglutin
could
absorb
treatment
serum
kaolin
rivanol
styk
et
al
two
reagent
howev
remov
substanti
amount
immunoglobulin
well
treatment
antisera
result
neglig
loss
antibodi
remov
nonspecif
inhibitor
inhibitori
activ
serotyp
found
plipoprotein
fraction
addit
mucoprotein
inhibitor
type
mann
et
al
consist
previou
find
nonspecif
inhibit
could
inactiv
phospholipas
c
schmidt
et
al
well
lecithinas
proteas
schmidt
et
al
among
picornavirus
predominantli
echo
group
coxsacki
viru
shown
hemagglutin
human
erythrocyt
goldfield
et
al
hemagglutin
appear
common
properti
mani
serotyp
strain
given
type
may
hemagglutin
howev
strain
hemagglutin
reaction
inhibit
typespecif
antibodi
optimum
ph
vari
strain
strain
also
optimum
temperatur
inde
basi
latter
variat
possibl
group
certain
serotyp
depend
maxim
activ
adult
newborn
human
erythrocyt
kern
rosen
extent
temperatur
depend
evid
strain
echo
virus
elut
erythrocyt
surfac
elut
leav
red
cell
surfac
still
capabl
adsorb
fresh
viru
reaction
consid
basi
nonenzymat
natur
podoplekin
dissect
hemagglutin
reaction
infer
may
made
natur
respons
viral
cell
receptor
compon
respect
hemagglutin
properti
resid
capsid
protein
sinc
complet
incomplet
viral
particl
antigen
ident
hemagglutin
shown
echo
viru
type
incomplet
particl
howev
found
less
stabl
heat
ether
treatment
find
import
rna
core
maintain
icosohedr
stabil
infer
fragment
coreless
particl
howev
without
detect
hemagglutin
activ
suggest
lower
size
limit
manifest
hemagglutin
halperen
et
al
thermal
labil
differ
echo
viru
hemagglutinin
vari
degre
shown
case
parallel
close
inactiv
infect
pattern
cation
stabil
hemagglutinin
infect
ident
strain
test
podoplekin
ivanova
moreov
rate
infect
inactiv
rapid
whole
viru
correspond
solubl
rna
observ
substanti
hypothesi
stabil
monoand
dival
cation
involv
primarili
capsid
evid
thc
chemic
natur
viral
compon
responsiblc
hemagglutin
reaction
hss
deriv
studi
cff
ect
variou
specif
carbohydras
proteas
reduc
elimin
hemagglutinin
complementari
evid
adduc
show
sever
aldos
capabl
bind
thc
crythrocytc
surfac
therebi
rendcr
cell
inagglutin
echo
virus
saccharid
attach
viral
particl
relat
appar
nuinher
carbon
atom
aldos
chain
inhibitori
potenc
lerner
et
al
result
suggest
hemagglutn
mtiy
br
effect
oligosaccliarid
residu
viral
capsid
reovirus
howev
valid
explan
must
await
direct
drmonstrat
oligosaccharid
viral
capsid
role
sh
group
capsid
also
examin
certain
sulfhydryl
reagent
notabl
pcmb
block
hemagglutin
activ
nurnbcr
cf
eriterovirus
echo
coxsacki
human
cell
effect
revers
thiol
compound
philipson
choppin
alkyl
agent
q
iodo
wctainid
inactiv
viral
hemagglutin
greater
ph
ph
sccmed
like
reaction
take
place
dissoci
mercaptid
rather
undissoci
group
sinc
known
dissoci
increas
pei
would
explain
parallel
increas
inactiv
iodoacetamid
inactiv
iodoacctamid
contrast
pcmb
irrevers
howev
retig
could
shown
block
experi
act
site
viral
particl
contrast
thc
sain
sulfhydryl
alkyl
reagent
effect
erythrocyt
surfac
respect
agglutin
enterovirus
trcatrrient
chymotrypsin
papain
result
loss
agglutinahil
echo
virus
imner
miranda
philipson
addit
chymotrypsin
alter
erythrocyt
crythrocytc
rnembranc
manner
viru
adsorb
indic
adsorpt
hemagglutin
activ
involv
protein
thc
erythrocyt
membran
receptor
echo
arid
coxsacki
virus
mwe
ident
one
anoth
philipson
bengtsson
studi
thc
dynam
viruserythrocyt
rcceptor
interact
reveal
two
stage
attach
cnterovirus
cell
membran
first
adsorpt
nonrlut
enterovirup
echo
coxsacki
w
l
rlativ
intiependcnt
temperatur
nonelut
virus
could
dissoci
erythrocyt
chyrriotrypsin
wti
follow
time
second
stage
character
resist
chymotrypsin
strain
could
shown
adsorb
elut
spontan
time
requir
elut
latter
instanc
requir
nonelut
virus
becom
resist
dissoci
receptor
chymotrypsin
ie
attain
second
stage
p
h
optimum
adsorpt
membran
resist
receptorviru
complex
dissoci
chymotrypsin
increas
ph
neutral
maxim
ph
ph
optimum
chymotrypsin
parallel
erythrocyteviru
system
first
stage
infect
suscept
host
cell
viru
attach
revers
first
time
show
progress
resist
dissoci
receptor
complex
chymotrypsin
resist
temperatur
depend
philipson
bengtsson
heat
labil
temperatur
depend
indic
second
stage
might
enzymemedi
reaction
host
cell
erythrocyt
attempt
made
character
chemic
natur
erythrocyt
receptor
materi
determin
mechan
interact
enterovirus
crude
membran
prepar
freezethaw
hemolysi
treat
nbutanol
presenc
solubl
inhibitori
materi
found
aqueou
portion
mixtur
solubl
materi
could
purifi
passag
sephadex
remov
lipoprotein
precipit
heparin
mncl
inhibitori
materi
elut
vo
volum
assum
molecular
weight
greater
analysi
show
presenc
protein
lipid
carbohydr
major
portion
latter
appear
bound
glycolipid
howev
lipid
extract
solubl
inhibitor
approxim
proteinbound
nana
found
deoxynucleotid
also
found
receptor
materi
doublestrand
dna
subsequ
identifi
hemoglobinfre
membran
prepar
red
cell
separ
leukocyt
lysi
although
leukocyt
therebi
exclud
contamin
sourc
still
possibl
dna
sourc
mere
occlud
erythrocyt
philipson
zetterqvist
n
accord
find
whole
membran
solubl
inhibitor
inactiv
enterovirus
capabl
agglutin
echo
coxsacki
incap
echo
polioviru
l
f
f
agglutin
human
cell
similarli
hemagglu
tinat
inhibitori
activ
destroy
treat
red
cell
fraction
papain
chymotrypsin
trypsin
venom
phosphodiesteras
period
sonic
interest
inhibitori
activ
solubl
materi
time
greater
hemagglutin
enterovirus
influenza
sendai
virus
consist
low
content
nana
suggest
receptor
activ
enterovirus
dependcd
peptid
involv
glycosid
linkag
oligosaccharid
residu
howev
overal
puriti
solubl
inhibitori
materi
difficult
assess
previou
experi
similar
fraction
suggest
sever
antigen
distinct
protein
involv
one
glycoprotein
tabl
macromolecular
natur
complex
moreov
ascrib
tendenc
erythrocyt
materi
aggreg
spontan
especi
aqueou
media
high
ionic
strength
evid
present
indic
solubl
purifi
erythrocyt
receptor
irrevers
bind
echo
viru
caus
releas
infect
viral
rna
signific
amount
ribonucleas
appear
prescnt
receptor
prepar
could
inhibit
dextran
sulfat
readili
shown
label
rna
releas
infect
mechan
releas
virusinhibitor
complex
remain
obscur
although
enzymat
process
propos
philipson
lind
reaction
hemagglutin
enterovirus
rcd
blood
cell
compon
thu
analog
first
stage
enterovir
penetr
eclips
host
cell
red
blood
cell
model
howev
shed
particular
light
biochem
sequenc
involv
indic
eclips
may
membran
mediat
degre
parallel
rcceptor
materi
red
blood
cell
thought
lipoprotein
inhibitori
substanc
demonstrahl
fluid
normal
infect
cell
cultur
schmidt
e
al
latter
inhibitor
suscept
chymotrypsin
trypsiii
papain
organ
solvent
thought
lipoprotein
natur
heatstabl
nonspecif
hemagglutin
inhibitor
present
mani
normal
anim
sera
schmidt
et
may
also
lipoprotein
phospholipid
protein
complex
sinc
inactiv
combin
chymotrypsin
phospholipas
c
filtrat
psychrophil
pseudcmonad
schmidt
et
ne
would
appear
insofar
tissu
cultur
serum
inhibitor
enterovir
hemagglutin
concern
polysaccharid
constitu
involv
sinc
neither
inhibitor
affect
rde
period
oxid
gener
resembl
solubl
inhibitor
erythrocyt
receptor
hemagglutin
enterovirus
thu
hold
basi
also
enterovir
receptor
may
said
differ
myxovirus
latter
highli
depend
certain
oligosaccharid
peptid
portion
mucopolysaccharid
cell
surfac
n
sum
evid
suggest
sh
group
virion
erythrocyt
surfac
essenti
hemagglutin
occur
attach
thu
simpli
establish
ss
bond
viru
cell
reagent
affect
sugar
glycosidas
kio
alkalin
borohydrid
inactiv
viral
hemagglutinin
compar
treatment
red
cell
interfer
reaction
fact
suggest
oligosaccharid
residu
capsid
may
effector
hemagglutinin
presenc
saccharid
virion
remain
demonstr
receptor
erythrocyt
well
suscept
host
cell
protein
andor
possibl
lipoprotein
evid
suggest
polysaccharid
membran
involv
role
lipid
obscur
charact
behavior
nonspecif
tissu
cultur
serum
hemagglutin
inhibitor
parallel
extent
receptor
materi
erythrocyt
insofar
character
rubella
virtu
order
detect
hemagglutinin
cell
cultur
infect
rubella
viru
nonspecif
inhibitor
must
remov
sera
use
mainten
medium
stewart
et
al
furukawa
et
al
accomplish
prior
adsorpt
sera
kaolin
clark
precipit
mann
et
al
altern
infect
cultur
maintain
serumfre
medium
sinc
viru
tend
remain
cell
associ
infect
cell
concentr
hemagglutinin
deriv
disintegr
cell
variou
method
combin
enhanc
hemagglutinin
titer
rubella
viru
prepar
viru
dissoci
inhibitor
versen
subsequ
treat
tween
furukawa
et
al
procedur
result
usual
loss
infect
analog
measl
viru
fragment
hemagglutinin
smaller
subunit
critic
condit
necessari
hemagglutin
rubella
compar
arbovirus
diluent
must
includ
dextran
gelatin
well
dival
cation
final
ph
addit
erythrocyt
must
stewart
et
al
schmidt
e
al
hemagglutin
take
place
best
avian
erythrocyt
particularli
goos
newli
hatch
chicken
pigeon
erythrocyt
mammalian
speci
nonreact
rubella
viru
adsorb
erythrocyt
elut
spontan
ph
maximum
agglutin
capabl
elut
rde
myxovirus
trypsin
furukawa
et
al
howev
addit
versen
elev
ph
caus
elut
viru
erythrocyt
receptor
remain
unalt
nonspecif
hemagglutin
inhibitor
present
human
anim
sera
thought
plipoprotein
sinc
inactiv
phospholipas
c
rel
heat
stabl
alreadi
note
precipit
dold
northrop
well
antibodi
plipoprotein
e
norrbi
therc
evid
suggest
serum
plipoprotcin
inhibitor
may
bear
analog
erythrocyt
reccptor
particularli
newli
hatch
chick
cell
morc
readili
agglutin
adult
cell
elcctron
microscop
studi
taylordickinson
et
al
show
presenc
lanthanum
stain
materi
heavi
electrondens
coat
present
erythrocyt
newli
hatch
chick
thc
materi
present
scanti
amount
adult
erythrocyt
treatment
thc
former
phospholipas
c
strip
cell
materi
render
inagglutin
viru
evid
forthcom
chemic
charact
materi
although
suggest
might
lipoprotein
act
receptor
viral
hemagglutinin
member
newli
dcfine
group
respiratori
agent
common
morphologicul
resembl
virus
avian
infecti
bronchiti
ibvlik
agent
mous
hepat
name
descript
electron
microscop
appear
viral
envelop
endow
regularli
array
clubshap
rod
peripher
subunit
larger
wide
space
spike
envelop
myxovirus
precisc
function
unknown
initi
coronavirus
found
agglutin
erythrocyt
howev
treatment
trypsin
ether
found
render
certain
strain
ibv
capabl
hemagglutin
corbo
cunningham
riswal
et
al
recent
two
human
strain
adapt
growth
suckl
mous
brain
concomit
changc
host
speci
virusspecif
agglutinin
wcre
found
associ
prepar
brain
antigen
high
infect
kay
dowdl
agglutin
activ
grcatest
rat
mous
chicken
erythrocyt
room
tcmperatur
hemagglutin
inhibit
specif
antibocli
unaffect
neuraminidas
treatment
erythrocyt
receptor
therefor
consid
differ
myxovirus
disrupt
viral
particl
deterg
ether
destroy
hemagglutin
activ
nonspecif
serum
inhibitor
roronaviru
hemagglutin
appar
occur
hemagglutin
goos
erythrocyt
rabi
viru
recent
report
hemagglutin
activ
associ
tissu
cultur
grown
rabi
viru
kuwert
e
al
halonen
et
al
depend
integr
capsid
protein
agglutin
appar
greater
artifici
releas
intracellular
viru
extracellular
ie
spontan
releas
viru
noninfect
solubl
hemagglutinin
found
cell
cultur
moreov
hemagglutinin
sensit
lipid
solvent
sh
reactiv
compound
maximum
hemagglutin
occur
p
h
adsorb
viru
elut
without
effect
evid
alter
receptor
treatment
erythrocyt
period
rde
effect
agglutin
cell
rabi
viru
proteolyt
enzym
lipid
solvent
ppropiolacton
sh
reactiv
compound
inactiv
hemagglutinin
latter
effect
infer
sh
group
involv
viral
attach
erythrocyt
receptor
natur
latter
howev
remain
obscur
high
titer
virionassoci
agglutinin
goos
erythrocyt
obtain
suspens
cultur
bhkpl
cell
infect
vesicular
stomat
viru
vsv
maintain
serumfre
medium
contain
bsa
contrast
rabi
vsv
hemagglutin
effect
ph
stabl
higher
temperatur
arstila
et
al
vsv
also
agglutin
erythrocyt
mammalian
speci
lower
titer
avian
erythrocyt
disrupt
virion
deterg
ether
destroy
hemagglutin
activ
indic
rabi
viru
intact
capsid
requir
hemagglutinin
similar
gener
properti
exhibit
sharp
strain
specif
respect
antibodi
inhibit
also
describ
kern
canyon
virus
halonen
e
al
polyoma
viru
agglutin
erythrocyt
variou
speci
mammalian
avian
although
consist
higher
titer
obtain
guinea
pig
erythrocyt
hartley
et
al
agglutin
take
place
wide
rang
ph
effici
p
h
neutral
specif
antibodi
erythrocyt
expos
rde
variou
influenza
virus
render
inagglutin
polyoma
polyoma
viru
howev
although
elut
effect
alter
erythrocyt
receptor
fogel
sach
find
along
inhibit
polyoma
hemagglutinin
ovornucin
hartley
ef
rdesensitivc
glycoprotein
inhibitor
bovinc
wrum
borecki
et
nl
provid
cvidencc
erythrocyt
receptor
polyoina
hemagglutinin
may
includ
thc
viru
reccptor
substanr
describ
connect
myxovirusc
recent
inform
structur
materi
vr
may
allow
elucid
interact
polyoma
erythrocyt
small
rna
virus
call
h
virus
found
agglutin
wide
varieti
mammalian
red
cell
pattern
among
differ
speci
quit
characterist
viru
strain
test
viru
widest
rang
alon
agglutin
gerbil
goos
cell
none
virus
react
chicken
erythrocyt
toolan
heatstabl
glycoprotein
inhibitor
found
hors
human
placent
fluid
compon
normal
serum
usateguigomez
et
al
inhibitor
human
fluid
activ
hb
virus
subsequ
shown
possess
alkalin
phosphatas
activ
usateguigomez
et
al
inhibitori
activ
host
placent
materi
destroy
sialidas
metaperiod
papain
trypsin
chymotrypsin
find
suggest
analog
receptor
erythrocyt
might
glycoprotein
natur
morpholog
resembl
rna
leukemia
virus
mice
myxovirus
prompt
unsuccess
search
licmagglutin
agent
recent
howev
bcen
shown
treatment
mous
leukemia
virusc
schsfer
neuraminidas
phospholipas
c
uncov
n
hemagglutinin
guinea
pig
erythrocyt
associ
viral
particl
neutral
typespecif
antivir
antibodi
mask
hemagglutinin
untreat
viral
particl
nscribcd
presenc
glycoprotein
phospholipid
compon
acquir
virion
thc
host
cell
membran
process
matur
releas
receptor
erythrocyt
unlik
myxovirus
resist
neuraminidas
thcre
evid
enzymenicdi
mcchanism
explain
elut
viru
agglutin
erythrocyt
direct
action
viral
particl
first
describ
connect
myxovirus
led
directli
discoveri
viral
ncuraminidas
properti
uniqu
myxovirus
paramyxovirus
thc
discoveri
hernagglutin
virus
taxonom
group
sinc
ad
new
dimens
studi
agent
antibodi
review
attempt
summar
current
knowledg
reaction
appli
virion
subunit
erythrocyt
membran
latter
subject
recent
intens
investig
small
portion
origin
connect
analysi
rnyxovir
hemagglutin
hemolysi
consider
insight
thu
gain
structur
cornpositon
erythrocyt
membran
use
viral
receptor
activ
blood
group
antigen
biolog
surfac
marker
precis
inform
avail
date
regard
viral
receptor
concern
myxovirus
rapidli
expand
knowledg
membran
structur
function
allow
elucid
othcr
viral
receptor
well
much
alreadi
learn
studi
receptor
analog
deriv
nonerythrocyt
sourc
tabl
pp
summar
princip
featur
character
hemagglutin
variou
member
princip
taxonom
group
virus
